🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Christopher Pasquale

Stock Analyst at Barclays

(4.42)
# 1,236
Out of 5,162 analysts
189
Total ratings
62.5%
Success rate
10.6%
Average return

Stocks Rated by Christopher Pasquale

Bausch + Lomb
Nov 17, 2026
Reiterated: Buy
Price Target: $24 → $27
Current: $20.69
Upside: +30.50%
Anteris Technologies Global
Nov 13, 2026
Reiterated: Hold
Price Target: $10 → $9
Current: $5.09
Upside: +76.82%
MiniMed Group
Nov 13, 2026
Reiterated: Hold
Price Target: $22 → $20
Current: $16.26
Upside: +23.00%
Alcon Inc.
Nov 11, 2026
Reiterated: Hold
Price Target: CHF 58.47 → CHF 66.82
Current: CHF 63.32
Upside: +5.53%
Humacyte
Nov 11, 2026
Reiterated: Hold
Price Target: $0.5 → $0.6
Current: $0.5425
Upside: +10.60%
Becton, Dickinson and Company
Nov 10, 2026
Reiterated: Sell
Price Target: $195
Current: $212.68
Upside: -8.31%
Baxter International
Nov 9, 2026
Reiterated: Sell
Price Target: $20 → $23
Current: $25.39
Upside: -9.41%
LivaNova
Nov 9, 2026
Reiterated: Buy
Price Target: $105 → $120
Current: $92.07
Upside: +30.34%
Senseonics Holdings
Nov 9, 2026
Reiterated: Hold
Price Target: $10 → $11
Current: $8.91
Upside: +23.53%
TransMedics Group
Nov 9, 2026
Reiterated: Buy
Price Target: $120
Current: $94.02
Upside: +27.63%
Reiterated: Hold
Price Target: $100 → $115
Current: $101.47
Upside: +13.33%
Reiterated: Hold
Price Target: $150 → $165
Current: $137.23
Upside: +20.24%
Reiterated: Hold
Price Target: $18 → $20
Current: $16.80
Upside: +19.05%
Reiterated: Buy
Price Target: $110 → $120
Current: $103.88
Upside: +15.52%
Reiterated: Buy
Price Target: $30
Current: $25.75
Upside: +16.50%
Reiterated: Sell
Price Target: $65 → $62
Current: $56.28
Upside: +10.16%
Reiterated: Hold
Price Target: $48 → $45
Current: $42.99
Upside: +4.68%
Reiterated: Buy
Price Target: $115 → $120
Current: $80.19
Upside: +49.64%
Reiterated: Buy
Price Target: $375 → $365
Current: $313.08
Upside: +16.58%
Reiterated: Buy
Price Target: $50 → $60
Current: $56.35
Upside: +6.48%
Reiterated: Buy
Price Target: $30
Current: $13.32
Upside: +125.23%
Reiterated: Buy
Price Target: $85 → $95
Current: $81.89
Upside: +16.01%
Reiterated: Hold
Price Target: $60
Current: $60.33
Upside: -0.55%
Reiterated: Buy
Price Target: $120
Current: $103.87
Upside: +15.53%
Reiterated: Buy
Price Target: $485 → $500
Current: $407.24
Upside: +22.78%
Initiated Coverage: Hold
Price Target: $120 → $95
Current: $100.61
Upside: -5.58%
Upgraded: Buy
Price Target: $305
Current: $320.01
Upside: n/a
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Reiterated: Buy
Price Target: $150
Current: $25.94
Upside: n/a
Reiterated: Buy
Price Target: $57 → $85
Current: $25.99
Upside: n/a
Upgraded: Buy
Price Target: $80
Current: $13.55
Upside: n/a